We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Appellate Court Overrides Hospira vs. Medicines Company
Federal Appellate Court Overrides Hospira vs. Medicines Company
The federal appellate court has ruled that the Medicines Company’s use of third-party suppliers to manufacture its blood thinner Angiomax does not invalidate the drug’s patents, reversing an earlier panel decision.